Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for S-Adenosyl-L-Methionine (SAMe).
SAMe serves as the primary methyl donor in the transmethylation cycle, critical for the synthesis of monoamine neurotransmitters, membrane phospholipids, and the maintenance of hepatic glutathione levels through the transsulfuration pathway.
34755
398.4 g/mol
-2.8
(2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]butanoate
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for S-Adenosyl-L-Methionine (SAMe) across standard consumer modalities.
Standard capsules require enteric coating to bypass gastric acidity and must be protected from moisture to prevent salt degradation.
The high hygroscopicity and sensitivity to aqueous environments make SAMe highly unstable in gummy matrices, leading to rapid loss of biological activity.
The high therapeutic dosage requirements of SAMe significantly exceed the physical loading capacity of thin-film oral delivery systems.
Ready to launch a product featuring S-Adenosyl-L-Methionine (SAMe)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your S-Adenosyl-L-Methionine (SAMe) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your S-Adenosyl-L-Methionine (SAMe) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation